会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Anti-Aβ oligomer humanized antibody
    • 反A&BGR 低聚物人源化抗体
    • US08303954B2
    • 2012-11-06
    • US12852581
    • 2010-08-09
    • Tsuguo KubotaNobuyuki Suzuki
    • Tsuguo KubotaNobuyuki Suzuki
    • A61K39/395C07K16/18
    • C07K16/18A61K2039/505C07K2317/24C07K2317/92C07K2319/00
    • An anti-cognitive dysfunction agent comprising a humanized antibody which does not bind to Aβ monomers and specifically binds only to Aβ oligomers and a fragment thereof as an active ingredient, and an therapeutic antibody which can be treat Alzheimer's disease by specifically binding amyloid β protein oligomer (Aβ oligomer) which is considered to be a cause of Alzheimer's disease are required. The present invention can provide an anti-Aβ oligomer humanized antibody and a method for treating Alzheimer's disease using the humanized antibody. An agent for treating Alzheimer's disease; an agent for suppressing formation of neuritic plaque; an inhibitor of formation of Aβ amyloid fiber; a method for at least one of preventing and treating cognitive dysfunction or Alzheimer's disease, comprising the step of administering the humanized antibody; and a method for suppressing progression of Alzheimer's disease, comprising the step of administering the humanized antibody.
    • 一种抗认知功能障碍剂,其包含不与Aβ结合的人源化抗体; 单体并且仅特异性结合A&bgr; 低聚物及其片段作为活性成分,以及可以通过特异性结合淀粉样蛋白来治疗阿尔茨海默氏病的治疗性抗体; 需要被认为是阿尔茨海默氏病的原因的蛋白质寡聚物(A&bgr;寡聚体)。 本发明可以提供抗A&Bgr; 低聚人源化抗体和使用人源化抗体治疗阿尔茨海默病的方法。 一种治疗阿尔茨海默氏病的药物; 抑制神经炎斑块形成的药剂; A&Bgr的形成抑制剂 淀粉样纤维; 一种预防和治疗认知功能障碍或阿尔茨海默氏病的方法,包括施用人源化抗体的步骤; 以及抑制阿尔茨海默病进展的方法,包括施用人源化抗体的步骤。
    • 9. 发明授权
    • Anti system ASC amino acid transporter 2 (ASCT2) antibody
    • 抗系统ASC氨基酸转运蛋白2(ASCT2)抗体
    • US08501180B2
    • 2013-08-06
    • US13008532
    • 2011-01-18
    • Tsuguo Kubota
    • Tsuguo Kubota
    • A61K39/395C07K16/18
    • C07K16/18C07K2317/24C07K2317/73C07K2317/734C07K2317/76G01N33/574
    • An object of the present invention is to provide a monoclonal antibody which is useful for treating or diagnosing a disease relating to system ASC amino acid transporter 2 (ASCT2) or a method using the antibody. The present invention provides a monoclonal antibody which specifically recognizes a native three-dimensional structure of an extracellular region of system ASC amino acid transporter 2 (ASCT2) and binds to the extracellular region, or an antibody fragment thereof; a hybridoma which produces the antibody; a DNA which encodes the antibody; a vector which contains the DNA; a transformant obtainable by introducing the vector; a process for producing an antibody or an antibody fragment thereof using the hybridoma or the transformant; and a therapeutic agent using the antibody or the antibody fragment thereof, and a diagnostic agent using the antibody or the antibody fragment thereof.
    • 本发明的目的是提供一种单克隆抗体,其可用于治疗或诊断与ASC系统ASC氨基酸转运蛋白2(ASCT2)有关的疾病或使用该抗体的方法。 本发明提供了特异性识别系统ASC氨基酸转运蛋白2(ASCT2)的细胞外区域的天然三维结构并结合细胞外区域或其抗体片段的单克隆抗体; 产生抗体的杂交瘤; 编码抗体的DNA; 含有DNA的载体; 通过引入载体可获得的转化体; 使用杂交瘤或转化体生产抗体或其抗体片段的方法; 以及使用该抗体或其抗体片段的治疗剂,以及使用该抗体或其抗体片段的诊断剂。